Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.565
Bid: 1.53
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.07 (4.575%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.565
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

Fri, 01st May 2020 11:18

(Alliance News) - The following is a round-up of quarterly, interim or full-year reports by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

InfraStrata PLC - natural gas storage and infrastructure - Pretax loss in six months to January 31 widens to GBP2.9 million from GBP394,627 amid sharp rise in management and administrative expenses to GBP2.8 million. Generates revenue of GBP515,230, versus none last year. Targets break-even at Harland & Wolff Belfast shipyard inside next 12 months.

----------

Flowtech Fluidpower PLC - fluid power components and services - Revenue in 2019 edges 0.3% higher to GBP112.4 million from GBP112.1 million, but pretax profit falls by 32% to GBP4.7 million from GBP6.9 million. Reports GBP1.7 million in depreciation of right-of-use assets, while administrative expenses rise 12% to GBP26.2 million. Decides against final dividend, means full-year payout down 65% to 2.13 pence per share from 6.07p.

----------

Block Energy PLC - exploration and production - Posts a widened pretax loss in 18 months to December 31. Previously changed its year-end date from June 30. Loss totalled USD6.1 million versus USD2.0 million. Generated revenue of USD314,000 versus USD179,000.

----------

Aminex PLC - oil & gas producer - Pretax loss in 2019 narrowed to USD15.2 million from USD48.5 million. Reported exploration impairments of USD10.9 million, down 75%. Revenue fell 42% to USD357,000 from USD617,000.

----------

Emmerson PLC - potash developer - Pretax loss in 2019 narrowed to GBP1.1 million from GBP1.8 million, amid absence of GBP698,000 in reverse acquisition expenses. Has moved to cut down on expenditure amid Covid-19.

----------

Taseko Mines Ltd - copper producer - Says revenue in three months to March 31 down 12% year-on-year to CAD62.1 million, about GBP35.2 million. Copper production up 30% to 32.4 million pounds from 24.9 million pounds.

----------

Panther Metals PLC - minerals explorer - Pretax loss in 2019 widened to GBP749,948 from GBP519,134 due to initial public offering costs of GBP305,134. Says outlook positive amid promising gold market.

----------

Shefa Gems Ltd - exploration and development - Swings to loss of NIS7.9 million, about GBP1.8 million, from NIS6.0 million. Aiming to continue mine planning procedures with the Israeli Lands Authority.

----------

Africa Opportunity Fund Ltd - investor - Net asset value per share at December 31 year-end down 4.9% to USD0.638 from USD0.671. Says performance lagged that of the Lusaka Stock Exchange in 2019.

----------

Marwyn Value Investors Ltd - investor - Reports share price total return of negative 17% compared to FTSE All-Share which gained 19%. Net assets down 29% to GBP105.0 million from GBP147.1 million.

----------

Papillon Holdings PLC - investment vehicle - Pretax loss in 2019 widens to GBP582,000 from GBP397,000. Administrative expenses up 20% to GBP443,000. Says acquisition of 50% stake in Pace Cloud Ltd progressing well.

----------

Golden Rock Global PLC - investment vehicle - Pretax loss in 2019 stretched to GBP393,871 from GBP227,983. Professional fees more than doubled to GBP272,308 during year where it came close to sealing acquisition before target company pulled out.

----------

New Century AIM VCT2 PLC - venture capital trust - 2019 NAV per share inches 2.4% higher to 49.53p from 48.38p, but axes dividend after 3.40p payout in 2018. Says UK general election result boosted certainty but notes volatility from Covid-19.

----------

Conygar Investment Co PLC - investor - Net asset value per share down 0.2% to 177.8 pence in six months to March 31 from 178.2p in September. NAV hurt by GBP1.3 million writedown at Cross Hands retail park in Carmarthenshire, Wales, due to Covid-19.

----------

Pires Investments PLC - investor - Net asset value in year ended October 31 climbs sharply to GBP2.6 million from GBP949,617 in year before. Pretax profit more than doubles to GBP865,510 from GBP322,069.

----------

Cardiff Property PLC - property investor - Ups dividend for six months to March 31 by 4.3% to 4.8 pence per share from 4.6p and NAV per share up 5.4% to 23.03p from 21.84p. Reports property market has uncertain picture due to Covid-19 but says Thames Valley area it operates in has been historically resilient.

----------

Weiss Korea Opportunity Fund Ltd - real estate investment - NAV per share rises 3.7% in 2019 to GBP1.5559 from GBP1.4993. Raises annual dividend by 21% to 4.1195p per share from 3.4155p. Noted that it outperformed the MSCI South Korea Index in 2019.

----------

Sigma Capital Group PLC - residential development - Revenue in 2019 rises 11% to GBP13.9 million from GBP12.5 million, with pretax profit climbing 17% to GBP13.0 million from GBP12.2 million. Holds total payout at 2.0p per share. Says Covid-19 impact difficult to predict. Will change year-end date to September 30 to better reflect season trading patterns.

----------

Highcroft Investments PLC - property investor - Net asset value per share falls 2.7% in 2019 to 1,175p from 1,205p. Slices final dividend by 20% to 27p per share from 33.75p, total payout down 8.6% to 48p from 52.50p. Net property income up 16% to GBP5.7 million and 12% rise in property valuation to GBP86.7 million from GBP77.7 million.

----------

Hemogenyx Pharmaceuticals PLC - cancer therapies - Pretax loss narrows to GBP1.5 million in 2019 from GBP1.6 million. Administrative expenses down 2.5% to GBP1.6 million and company reports other income of GBP213,126, more than double the amount from 2018.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2023 19:43

IN BRIEF: Hemogenyx Pharmaceuticals says patent number published

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for blood diseases - Says its patent application number "WO2023168292 Chimeric Bait Receptors and Uses Thereof" was published by the World Intellectual Property Organization on Thursday. Says it remains to be reviewed and approved by national patent authorities.

Read more
10 Jul 2023 10:27

Hemogenyx says Hemo-Car-T treatment placed on clinical hold by US FDA

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has received a review letter from the US Food & Drug Administration confirming its placement of Hemo-Car-T on clinical hold.

Read more
23 Jun 2023 15:51

UK shareholder meetings calendar - next 7 days

Monday 26 June 
Aterian PLCAGM
Capricorn Energy PLCAGM
Corre Energy BVAGM
Facilities by ADF PLCAGM
Lexington Gold LtdSGM re proposed acquisition of White Rivers Exploration Ltd
LifeSafe Holdings PLCAGM
Premier African Minerals LtdAGM
Vast Resources PLCGM re issuing new share capital
Volvere PLCAGM
Tuesday 27 June 
Acuity RM Group PLCAGM
Comptoir Group PLCAGM
Creo Medical Group PLCAGM
First Tin PLCAGM
Forward Partners Group PLCAGM
Galantas Gold CorpAGM
Gemfields Group LtdAGM
Golden Prospect Precious Metals LtdAGM
Hamak Gold LtdAGM
ICG Enterprise Trust PLCAGM
Impellam Group PLCAGM
India Capital Growth Fund LtdAGM
Inspiration Healthcare Group PLCAGM
Instem PLCAGM
JD Sports Fashion PLCAGM
Kingfisher PLCAGM
Mercantile Ports & Logistics LtdGM re equity fundraising
Mobile Tornado Group PLCAGM
Revolution Beauty Group PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serabi Gold PLCAGM
Sondrel Holdings PLCAGM
Surface Transforms PLCAGM
Surgical Innovations Group PLCAGM
Trinity Exploration & Production PLCAGM
Wednesday 28 June 
Atalaya Mining PLCAGM
Avacta Group PLCAGM
Boku IncAGM
Cambridge Cognition Holdings PLCAGM
Cizzle Biotechnology Holdings PLCAGM
Cobra Resources PLCAGM
Cora Gold LtdAGM
Dial Square Investments PLCAGM
Itaconix PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Panthera Resources PLCGM re directors’ authority to allot shares
Phoenix Spree Deutschland LtdAGM
Pineapple Power Corp PLCAGM
Polarean Imaging PLCAGM
RA International Group PLCAGM
Schroder European Real Estate Investment Trust PLCAGM
Shield Therapeutics PLCAGM
St Mark Homes PLCAGM
Star Phoenix Group LtdAGM
ValiRx PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Warpaint London PLCAGM
Westminster Group PLCAGM
Zenova Group PLCAGM
Thursday 29 June 
3i Group PLCAGM
Africa Opportunity Fund LtdAGM
Anemoi International LtdAGM
Anpario PLCAGM
Ariana Resources PLCAGM
Beowulf Mining PLCAGM
Celadon Pharmaceuticals PLCAGM
Cornish Metals IncAGM
East Imperial PLCAGM
East Star Resources PLCAGM
Eden Research PLCAGM
Engage XR Holdings PLCAGM
First Class Metals PLCAGM
Gresham House Energy Storage Fund PLCGM re remuneration policy
Gusbourne PLCAGM
HeiQ PLCAGM
Helios Underwriting PLCAGM
Ingenta PLCAGM
IQE PLCAGM
Kooth PLCAGM
Landore Resources LtdAGM
Let's Explore Group PLCAGM
Likewise Group PLCAGM
MGC Pharmaceuticals LtdGM re issue of convertible notes
Morgan Advanced Materials PLCAGM
NetScientific PLCAGM
New Century AIM VCT 2AGM
Norman Broadbent PLCAGM
Reabold Resources PLCAGM
Rockhopper Exploration PLCAGM
Roquefort Therapeutics PLCAGM
Serica Energy PLCAGM
SpaceandPeople PLCAGM
Symphony Environmental Technologies PLCAGM
Synairgen PLCAGM
Thalassa Holdings LtdAGM
tinyBuild IncAGM
Touchstone Exploration IncAGM
Trident Royalties PLCAGM
Unigel Group PLCAGM
Verici Dx PLCAGM
Xpediator PLCAGM
Friday 30 June 
Argo Blockchain PLCAGM
Ascent Resources PLCAGM
Bluejay Mining PLCAGM
Caspian Sunrise PLCAGM
Codex Acquisitions PLCAGM
Domino's Pizza Group PLCGM re directors' remuneration policy
Fenikso LtdAGM
Fiinu PLCAGM
FireAngel Safety Technology Group PLCAGM
GENinCode PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Hiro Metaverse Acquisitions I SAAGM
i3 Energy PLCGM re premium share cancellation
ImmuPharma PLCAGM
Inspired PLCAGM
Jadestone Energy PLCAGM
Kanabo Group PLCAGM
Kefi Gold & Copper PLCAGM
Kistos Holdings PLCAGM
KRM22 PLCAGM
Kropz PLCAGM
LoopUp Group PLCAGM
Medica Group PLCAGM
Mirriad Advertising PLCAGM
Rockfire Resources PLCAGM
Savannah Energy PLCAGM
Strip Tinning Holdings PLCAGM
ThomasLloyd Energy Impact Trust PLCAGM
URA Holdings PLCAGM
World Chess PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
2 Jun 2023 13:08

IN BRIEF: Hemogenyx announces clinical hold for Hemo-Car-T treatment

Hemogenyx Pharmaceuticals PLC -hemo London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Notes receipt of notice from the US Food & Drug Administration over its investigational new drug application for its product candidate Chimeric Antigen Receptor T-cells, or Hemo-Car-T. Says Hemo-Car-T is a treatment for acute myeloid leukemia. Says FDA put Hemo-Car-T on clinical hold, pending an FDA letter to be received within 30 days detailing what additional information needs to be provided by Hemogenyx. Hemogenyx submitted the investigational new drug application in early May, seeking authorisation to begin a phase 1 clinical trial of Hemo-Car-T.

Read more
9 May 2023 15:16

IN BRIEF: Hemogenyx submits FDA application for Hemo-Car-T treatment

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Submits investigational new drug application seeking authorisation from the US Food & Drug Administration to begin a phase 1 clinical trial of its lead product chemic antigen receptor T-cells, or Hemo-Car-T, for treating acute myeloid leukemia.

Read more
28 Apr 2023 15:35

EARNINGS SUMMARY: DP Aircraft profit swing, Chesterfield loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Read more
23 Mar 2023 20:32

TRADING UPDATES: Fragrant Prosperity to buy Hi 55, Oscillate talks end

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday not separately reported by Alliance News:

Read more
26 Jan 2023 10:45

Hemogenyx raises GBP4 million in share placing for Hemo-CAR-T product

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it successfully raised GBP4.1 million in a placing of new shares, with the fresh cash to be used to progress its Hemo-CAR-T product candidate into clinical trials.

Read more
23 Jan 2023 16:59

IN BRIEF: Hemogenyx completes process run for HEMO-CAR-T manufacture

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical group developing new therapies and treatments for deadly blood diseases - Completes third process qualification run for the manufacture of HEMO-CAR-T cells. Says the HEMO-CAR-T cells will be tested by third party to ensure quality. The three process runs are required by the US Food & Drug Administration to begin clinical trials. Following completion of all tests across all PQ runs, data will be compiled for inclusion in the investigational new drug submission pack. HEMO-CAR-T cells are being developed the potential treatment of acute myeloid leukemia, a blood and bone marrow cancer.

Read more
9 Jan 2023 10:21

Hemogenyx shares up on single target protein virus treatment finding

(Alliance News) - Hemogenyx Pharmaceuticals PLC shares jumped early Monday, after the company announced the discovery of a single target protein for use against multiple dangerous viruses.

Read more
4 Jan 2023 11:12

IN BRIEF: Hemogenyx Pharma second process qualification run successful

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - Successfully completes its second process qualification run of the end-to-end process for the manufacture of HEMO-CAR-T cells. The company says it was followed by analytical release tests to verify the quality of the manufactured cells. The run is the second of three identical manufacturing runs required by the US Food and Drug Administration for the submission of an investigational new drug application. The IND application is needed in order to commence phase one clinical trials of HEMO-CAR-T cells.

Read more
4 Jan 2023 10:36

SMALL-CAP WINNERS & LOSERS: HeiQ drops on expectation of lower sales

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Wednesday.

Read more
18 Nov 2022 16:21

Hemogenyx makes final development run of HEMO-CAR-T cell manufacture

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said it has completed the final development run for its manufacturing process of HEMO-CAR-T cells.

Read more
29 Sep 2022 15:09

EARNINGS UPDATES: Hemogenyx hopes on cancer drug; IDE loss widens

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
15 Aug 2022 09:50

Hemogenyx wins patent for bi-specific antibody method in China

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it has been awarded a patent for its bi-specific antibody in China.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.